Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma

Overview of attention for article published in Journal of Zhejiang University - Science B, December 2019

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,524 followers.

Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma. #lymphoma #lymsm https://t.co/97dJMWhL23

Reply Repost Favourite

PC | Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma. https://t.co/n9sGTJryjk

Reply Repost Favourite

New article: Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma. https://t.co/0RlNNc7y8o #DLBCL #lymsm #hematology

Reply Repost Favourite